Literature DB >> 28100740

Epilepsy-Associated KCNQ2 Channels Regulate Multiple Intrinsic Properties of Layer 2/3 Pyramidal Neurons.

Zachary Niday1, Virginia E Hawkins1, Heun Soh1, Daniel K Mulkey1, Anastasios V Tzingounis2.   

Abstract

KCNQ2 potassium channels are critical for normal brain function, as both loss-of-function and gain-of-function KCNQ2 variants can lead to various forms of neonatal epilepsy. Despite recent progress, the full spectrum of consequences as a result of KCNQ2 dysfunction in neocortical pyramidal neurons is still unknown. Here, we report that conditional ablation of Kcnq2 from mouse neocortex leads to hyperexcitability of layer 2/3 (L2/3) pyramidal neurons, exhibiting an increased input resistance and action potential frequency, as well as a reduced medium afterhyperpolarization (mAHP), a conductance partly mediated by KCNQ2 channels. Importantly, we show that introducing the KCNQ2 loss-of-function variant KCNQ2I205V into L2/3 pyramidal neurons using in utero electroporation also results in a hyperexcitable phenotype similar to the conditional knock-out. KCNQ2I205V has a right-shifted conductance-to-voltage relationship, suggesting loss of KCNQ2 channel activity at subthreshold membrane potentials is sufficient to drive large changes in L2/3 pyramidal neuronal excitability even in the presence of an intact mAHP. We also found that the changes in excitability following Kcnq2 ablation are accompanied by alterations at action potential properties, including action potential amplitude in Kcnq2-null neurons. Importantly, partial inhibition of Nav1.6 channels was sufficient to counteract the hyperexcitability of Kcnq2-null neurons. Therefore, our work shows that loss of KCNQ2 channels alters the intrinsic neuronal excitability and action potential properties of L2/3 pyramidal neurons, and identifies Nav1.6 as a new potential molecular target to reduce excitability in patients with KCNQ2 encephalopathy. SIGNIFICANCE STATEMENT: KCNQ2 channels are critical for the development of normal brain function, as KCNQ2 variants could lead to epileptic encephalopathy. However, the role of KCNQ2 channels in regulating the properties of neocortical neurons is largely unexplored. Here, we find that Kcnq2 ablation or loss-of-function at subthreshold membrane potentials leads to increased neuronal excitability of neocortical layer 2/3 (L2/3) pyramidal neurons. We also demonstrate that Kcnq2 ablation unexpectedly leads to a larger action potential amplitude. Importantly, we propose the Nav1.6 channel as a new molecular target for patients with KCNQ2 encephalopathy, as partial inhibition of these channels counteracts the increased L2/3 pyramidal neuron hyperexcitability of Kcnq2-null neurons.
Copyright © 2017 the authors 0270-6474/17/370576-11$15.00/0.

Entities:  

Keywords:  KCNQ2; KCNQ3; epilepsy; potassium channels; sodium channels

Mesh:

Substances:

Year:  2017        PMID: 28100740      PMCID: PMC5242407          DOI: 10.1523/JNEUROSCI.1425-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

Authors:  Sarah Weckhuysen; Simone Mandelstam; Arvid Suls; Dominique Audenaert; Tine Deconinck; Lieve R F Claes; Liesbet Deprez; Katrien Smets; Dimitrina Hristova; Iglika Yordanova; Albena Jordanova; Berten Ceulemans; An Jansen; Danièle Hasaerts; Filip Roelens; Lieven Lagae; Simone Yendle; Thorsten Stanley; Sarah E Heron; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer; Peter de Jonghe
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

2.  Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons.

Authors:  Michel Royeck; Marie-Therese Horstmann; Stefan Remy; Margit Reitze; Yoel Yaari; Heinz Beck
Journal:  J Neurophysiol       Date:  2008-07-23       Impact factor: 2.714

3.  Contribution of tumor heterogeneity in a new animal model of CNS tumors.

Authors:  Fuyi Chen; Albert J Becker; Joseph J LoTurco
Journal:  Mol Cancer Res       Date:  2014-02-05       Impact factor: 5.852

4.  Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons.

Authors:  Arne Battefeld; Baouyen T Tran; Jason Gavrilis; Edward C Cooper; Maarten H P Kole
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

5.  The preclinical discovery and development of ezogabine for the treatment of epilepsy.

Authors:  Slobodan Jankovic; Ivana Ilickovic
Journal:  Expert Opin Drug Discov       Date:  2013-09-21       Impact factor: 6.098

6.  Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures.

Authors:  Francesca Boscia; Lucio Annunziato; Maurizio Taglialatela
Journal:  Neuropharmacology       Date:  2006-05-11       Impact factor: 5.250

7.  Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.

Authors:  H Christian Peters; Hua Hu; Olaf Pongs; Johan F Storm; Dirk Isbrandt
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

Review 8.  The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.

Authors:  Martin J Gunthorpe; Charles H Large; Raman Sankar
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

9.  Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.

Authors:  Nanda A Singh; James F Otto; E Jill Dahle; Chris Pappas; Jonathan D Leslie; Alex Vilaythong; Jeffrey L Noebels; H Steve White; Karen S Wilcox; Mark F Leppert
Journal:  J Physiol       Date:  2008-05-15       Impact factor: 5.182

10.  Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.

Authors:  Mustafa S Hamada; Maarten H P Kole
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

View more
  15 in total

1.  Differential Control of Axonal and Somatic Resting Potential by Voltage-Dependent Conductances in Cortical Layer 5 Pyramidal Neurons.

Authors:  Wenqin Hu; Bruce P Bean
Journal:  Neuron       Date:  2018-03-08       Impact factor: 17.173

2.  Posttranscriptional modulation of KCNQ2 gene expression by the miR-106b microRNA family.

Authors:  Kwon-Woo Kim; Keetae Kim; Hee-Jin Kim; Byeol-I Kim; Myungin Baek; Byung-Chang Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

3.  Differential processing and localization of human Nocturnin controls metabolism of mRNA and nicotinamide adenine dinucleotide cofactors.

Authors:  Elizabeth T Abshire; Kelsey L Hughes; Rucheng Diao; Sarah Pearce; Shreekara Gopalakrishna; Raymond C Trievel; Joanna Rorbach; Peter L Freddolino; Aaron C Goldstrohm
Journal:  J Biol Chem       Date:  2020-08-23       Impact factor: 5.157

4.  Gq-Coupled Muscarinic Receptor Enhancement of KCNQ2/3 Channels and Activation of TRPC Channels in Multimodal Control of Excitability in Dentate Gyrus Granule Cells.

Authors:  Chase M Carver; Mark S Shapiro
Journal:  J Neurosci       Date:  2018-12-28       Impact factor: 6.167

5.  Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K+ channel plasticity.

Authors:  Chase M Carver; Shayne D Hastings; Mileah E Cook; Mark S Shapiro
Journal:  Hippocampus       Date:  2019-10-17       Impact factor: 3.899

6.  Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay Syndrome.

Authors:  Pedro A Lazo; Juan L García; Paulino Gómez-Puertas; Íñigo Marcos-Alcalde; Cesar Arjona; Alvaro Villarroel; Rogelio González-Sarmiento; Carmen Fons
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

7.  KCNQ2-Neonatal Epileptic Encephalopathy Complicated by Ventricular Tachycardia: A Case Report.

Authors:  Yuehang Geng; Xinlin Hou
Journal:  Front Neurol       Date:  2020-04-17       Impact factor: 4.003

8.  A Brain Signaling Framework for Stress-Induced Depression and Ketamine Treatment Elucidated by Phosphoproteomics.

Authors:  Yan Xiao; Huoqing Luo; Wen Z Yang; Yeting Zeng; Yinbo Shen; Xinyan Ni; Zhaomei Shi; Jun Zhong; Ziqi Liang; Xiaoyu Fu; Hongqing Tu; Wenzhi Sun; Wei L Shen; Ji Hu; Jiajun Yang
Journal:  Front Cell Neurosci       Date:  2020-04-07       Impact factor: 5.505

9.  A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.

Authors:  Mathieu Milh; Pierre Roubertoux; Najoua Biba; Julie Chavany; Adeline Spiga Ghata; Camille Fulachier; Stephan Christopher Collins; Christel Wagner; Jean-Christophe Roux; Binnaz Yalcin; Marie-Solenne Félix; Florence Molinari; Pierre-Pascal Lenck-Santini; Laurent Villard
Journal:  Epilepsia       Date:  2020-04-02       Impact factor: 5.864

Review 10.  The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding.

Authors:  Nina Dirkx; Francesco Miceli; Maurizio Taglialatela; Sarah Weckhuysen
Journal:  Front Physiol       Date:  2020-10-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.